Global Long Acting Insulins Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Long Acting Insulins market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Long Acting Insulins (are also called basal or background insulins) can control blood sugar for an entire day. Bovine PZI (protamine zinc insulin), can last anywhere up to 36 hours. Long acting insulins are available in animal and analogue forms. They can be used for a number of different types of diabetes.
The Global Info Research report includes an overview of the development of the Long Acting Insulins industry chain, the market status of Home Use (Insulin Glargine, Insulin Determir), Medical Institutions (Insulin Glargine, Insulin Determir), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Long Acting Insulins.
Regionally, the report analyzes the Long Acting Insulins markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Long Acting Insulins market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Long Acting Insulins market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Long Acting Insulins industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Insulin Glargine, Insulin Determir).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Long Acting Insulins market.
Regional Analysis: The report involves examining the Long Acting Insulins market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Long Acting Insulins market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Long Acting Insulins:
Company Analysis: Report covers individual Long Acting Insulins players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Long Acting Insulins This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Home Use, Medical Institutions).
Technology Analysis: Report covers specific technologies relevant to Long Acting Insulins. It assesses the current state, advancements, and potential future developments in Long Acting Insulins areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Long Acting Insulins market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Long Acting Insulins market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Long Acting Insulins product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Long Acting Insulins, with revenue, gross margin and global market share of Long Acting Insulins from 2019 to 2024.
Chapter 3, the Long Acting Insulins competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Long Acting Insulins market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Long Acting Insulins.
Chapter 13, to describe Long Acting Insulins research findings and conclusion.
Long Acting Insulins (are also called basal or background insulins) can control blood sugar for an entire day. Bovine PZI (protamine zinc insulin), can last anywhere up to 36 hours. Long acting insulins are available in animal and analogue forms. They can be used for a number of different types of diabetes.
The Global Info Research report includes an overview of the development of the Long Acting Insulins industry chain, the market status of Home Use (Insulin Glargine, Insulin Determir), Medical Institutions (Insulin Glargine, Insulin Determir), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Long Acting Insulins.
Regionally, the report analyzes the Long Acting Insulins markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Long Acting Insulins market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Long Acting Insulins market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Long Acting Insulins industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Insulin Glargine, Insulin Determir).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Long Acting Insulins market.
Regional Analysis: The report involves examining the Long Acting Insulins market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Long Acting Insulins market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Long Acting Insulins:
Company Analysis: Report covers individual Long Acting Insulins players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Long Acting Insulins This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Home Use, Medical Institutions).
Technology Analysis: Report covers specific technologies relevant to Long Acting Insulins. It assesses the current state, advancements, and potential future developments in Long Acting Insulins areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Long Acting Insulins market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Long Acting Insulins market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Insulin Glargine
- Insulin Determir
- Insulin Degludec
- Long Acting Animal Insulin
- Home Use
- Medical Institutions
- Others
- Novo Nordisk
- Sanofi
- Wockhardt UK
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Long Acting Insulins product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Long Acting Insulins, with revenue, gross margin and global market share of Long Acting Insulins from 2019 to 2024.
Chapter 3, the Long Acting Insulins competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Long Acting Insulins market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Long Acting Insulins.
Chapter 13, to describe Long Acting Insulins research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Long Acting Insulins
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Long Acting Insulins by Type
1.3.1 Overview: Global Long Acting Insulins Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Long Acting Insulins Consumption Value Market Share by Type in 2023
1.3.3 Insulin Glargine
1.3.4 Insulin Determir
1.3.5 Insulin Degludec
1.3.6 Long Acting Animal Insulin
1.4 Global Long Acting Insulins Market by Application
1.4.1 Overview: Global Long Acting Insulins Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Home Use
1.4.3 Medical Institutions
1.4.4 Others
1.5 Global Long Acting Insulins Market Size & Forecast
1.6 Global Long Acting Insulins Market Size and Forecast by Region
1.6.1 Global Long Acting Insulins Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Long Acting Insulins Market Size by Region, (2019-2030)
1.6.3 North America Long Acting Insulins Market Size and Prospect (2019-2030)
1.6.4 Europe Long Acting Insulins Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Long Acting Insulins Market Size and Prospect (2019-2030)
1.6.6 South America Long Acting Insulins Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Long Acting Insulins Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Novo Nordisk
2.1.1 Novo Nordisk Details
2.1.2 Novo Nordisk Major Business
2.1.3 Novo Nordisk Long Acting Insulins Product and Solutions
2.1.4 Novo Nordisk Long Acting Insulins Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Novo Nordisk Recent Developments and Future Plans
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Long Acting Insulins Product and Solutions
2.2.4 Sanofi Long Acting Insulins Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sanofi Recent Developments and Future Plans
2.3 Wockhardt UK
2.3.1 Wockhardt UK Details
2.3.2 Wockhardt UK Major Business
2.3.3 Wockhardt UK Long Acting Insulins Product and Solutions
2.3.4 Wockhardt UK Long Acting Insulins Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Wockhardt UK Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Long Acting Insulins Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Long Acting Insulins by Company Revenue
3.2.2 Top 3 Long Acting Insulins Players Market Share in 2023
3.2.3 Top 6 Long Acting Insulins Players Market Share in 2023
3.3 Long Acting Insulins Market: Overall Company Footprint Analysis
3.3.1 Long Acting Insulins Market: Region Footprint
3.3.2 Long Acting Insulins Market: Company Product Type Footprint
3.3.3 Long Acting Insulins Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Long Acting Insulins Consumption Value and Market Share by Type (2019-2024)
4.2 Global Long Acting Insulins Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Long Acting Insulins Consumption Value Market Share by Application (2019-2024)
5.2 Global Long Acting Insulins Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Long Acting Insulins Consumption Value by Type (2019-2030)
6.2 North America Long Acting Insulins Consumption Value by Application (2019-2030)
6.3 North America Long Acting Insulins Market Size by Country
6.3.1 North America Long Acting Insulins Consumption Value by Country (2019-2030)
6.3.2 United States Long Acting Insulins Market Size and Forecast (2019-2030)
6.3.3 Canada Long Acting Insulins Market Size and Forecast (2019-2030)
6.3.4 Mexico Long Acting Insulins Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Long Acting Insulins Consumption Value by Type (2019-2030)
7.2 Europe Long Acting Insulins Consumption Value by Application (2019-2030)
7.3 Europe Long Acting Insulins Market Size by Country
7.3.1 Europe Long Acting Insulins Consumption Value by Country (2019-2030)
7.3.2 Germany Long Acting Insulins Market Size and Forecast (2019-2030)
7.3.3 France Long Acting Insulins Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Long Acting Insulins Market Size and Forecast (2019-2030)
7.3.5 Russia Long Acting Insulins Market Size and Forecast (2019-2030)
7.3.6 Italy Long Acting Insulins Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Long Acting Insulins Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Long Acting Insulins Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Long Acting Insulins Market Size by Region
8.3.1 Asia-Pacific Long Acting Insulins Consumption Value by Region (2019-2030)
8.3.2 China Long Acting Insulins Market Size and Forecast (2019-2030)
8.3.3 Japan Long Acting Insulins Market Size and Forecast (2019-2030)
8.3.4 South Korea Long Acting Insulins Market Size and Forecast (2019-2030)
8.3.5 India Long Acting Insulins Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Long Acting Insulins Market Size and Forecast (2019-2030)
8.3.7 Australia Long Acting Insulins Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Long Acting Insulins Consumption Value by Type (2019-2030)
9.2 South America Long Acting Insulins Consumption Value by Application (2019-2030)
9.3 South America Long Acting Insulins Market Size by Country
9.3.1 South America Long Acting Insulins Consumption Value by Country (2019-2030)
9.3.2 Brazil Long Acting Insulins Market Size and Forecast (2019-2030)
9.3.3 Argentina Long Acting Insulins Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Long Acting Insulins Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Long Acting Insulins Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Long Acting Insulins Market Size by Country
10.3.1 Middle East & Africa Long Acting Insulins Consumption Value by Country (2019-2030)
10.3.2 Turkey Long Acting Insulins Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Long Acting Insulins Market Size and Forecast (2019-2030)
10.3.4 UAE Long Acting Insulins Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Long Acting Insulins Market Drivers
11.2 Long Acting Insulins Market Restraints
11.3 Long Acting Insulins Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Long Acting Insulins Industry Chain
12.2 Long Acting Insulins Upstream Analysis
12.3 Long Acting Insulins Midstream Analysis
12.4 Long Acting Insulins Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Long Acting Insulins
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Long Acting Insulins by Type
1.3.1 Overview: Global Long Acting Insulins Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Long Acting Insulins Consumption Value Market Share by Type in 2023
1.3.3 Insulin Glargine
1.3.4 Insulin Determir
1.3.5 Insulin Degludec
1.3.6 Long Acting Animal Insulin
1.4 Global Long Acting Insulins Market by Application
1.4.1 Overview: Global Long Acting Insulins Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Home Use
1.4.3 Medical Institutions
1.4.4 Others
1.5 Global Long Acting Insulins Market Size & Forecast
1.6 Global Long Acting Insulins Market Size and Forecast by Region
1.6.1 Global Long Acting Insulins Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Long Acting Insulins Market Size by Region, (2019-2030)
1.6.3 North America Long Acting Insulins Market Size and Prospect (2019-2030)
1.6.4 Europe Long Acting Insulins Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Long Acting Insulins Market Size and Prospect (2019-2030)
1.6.6 South America Long Acting Insulins Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Long Acting Insulins Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Novo Nordisk
2.1.1 Novo Nordisk Details
2.1.2 Novo Nordisk Major Business
2.1.3 Novo Nordisk Long Acting Insulins Product and Solutions
2.1.4 Novo Nordisk Long Acting Insulins Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Novo Nordisk Recent Developments and Future Plans
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Long Acting Insulins Product and Solutions
2.2.4 Sanofi Long Acting Insulins Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sanofi Recent Developments and Future Plans
2.3 Wockhardt UK
2.3.1 Wockhardt UK Details
2.3.2 Wockhardt UK Major Business
2.3.3 Wockhardt UK Long Acting Insulins Product and Solutions
2.3.4 Wockhardt UK Long Acting Insulins Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Wockhardt UK Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Long Acting Insulins Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Long Acting Insulins by Company Revenue
3.2.2 Top 3 Long Acting Insulins Players Market Share in 2023
3.2.3 Top 6 Long Acting Insulins Players Market Share in 2023
3.3 Long Acting Insulins Market: Overall Company Footprint Analysis
3.3.1 Long Acting Insulins Market: Region Footprint
3.3.2 Long Acting Insulins Market: Company Product Type Footprint
3.3.3 Long Acting Insulins Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Long Acting Insulins Consumption Value and Market Share by Type (2019-2024)
4.2 Global Long Acting Insulins Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Long Acting Insulins Consumption Value Market Share by Application (2019-2024)
5.2 Global Long Acting Insulins Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Long Acting Insulins Consumption Value by Type (2019-2030)
6.2 North America Long Acting Insulins Consumption Value by Application (2019-2030)
6.3 North America Long Acting Insulins Market Size by Country
6.3.1 North America Long Acting Insulins Consumption Value by Country (2019-2030)
6.3.2 United States Long Acting Insulins Market Size and Forecast (2019-2030)
6.3.3 Canada Long Acting Insulins Market Size and Forecast (2019-2030)
6.3.4 Mexico Long Acting Insulins Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Long Acting Insulins Consumption Value by Type (2019-2030)
7.2 Europe Long Acting Insulins Consumption Value by Application (2019-2030)
7.3 Europe Long Acting Insulins Market Size by Country
7.3.1 Europe Long Acting Insulins Consumption Value by Country (2019-2030)
7.3.2 Germany Long Acting Insulins Market Size and Forecast (2019-2030)
7.3.3 France Long Acting Insulins Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Long Acting Insulins Market Size and Forecast (2019-2030)
7.3.5 Russia Long Acting Insulins Market Size and Forecast (2019-2030)
7.3.6 Italy Long Acting Insulins Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Long Acting Insulins Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Long Acting Insulins Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Long Acting Insulins Market Size by Region
8.3.1 Asia-Pacific Long Acting Insulins Consumption Value by Region (2019-2030)
8.3.2 China Long Acting Insulins Market Size and Forecast (2019-2030)
8.3.3 Japan Long Acting Insulins Market Size and Forecast (2019-2030)
8.3.4 South Korea Long Acting Insulins Market Size and Forecast (2019-2030)
8.3.5 India Long Acting Insulins Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Long Acting Insulins Market Size and Forecast (2019-2030)
8.3.7 Australia Long Acting Insulins Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Long Acting Insulins Consumption Value by Type (2019-2030)
9.2 South America Long Acting Insulins Consumption Value by Application (2019-2030)
9.3 South America Long Acting Insulins Market Size by Country
9.3.1 South America Long Acting Insulins Consumption Value by Country (2019-2030)
9.3.2 Brazil Long Acting Insulins Market Size and Forecast (2019-2030)
9.3.3 Argentina Long Acting Insulins Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Long Acting Insulins Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Long Acting Insulins Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Long Acting Insulins Market Size by Country
10.3.1 Middle East & Africa Long Acting Insulins Consumption Value by Country (2019-2030)
10.3.2 Turkey Long Acting Insulins Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Long Acting Insulins Market Size and Forecast (2019-2030)
10.3.4 UAE Long Acting Insulins Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Long Acting Insulins Market Drivers
11.2 Long Acting Insulins Market Restraints
11.3 Long Acting Insulins Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Long Acting Insulins Industry Chain
12.2 Long Acting Insulins Upstream Analysis
12.3 Long Acting Insulins Midstream Analysis
12.4 Long Acting Insulins Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Long Acting Insulins Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Long Acting Insulins Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Long Acting Insulins Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Long Acting Insulins Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Novo Nordisk Company Information, Head Office, and Major Competitors
Table 6. Novo Nordisk Major Business
Table 7. Novo Nordisk Long Acting Insulins Product and Solutions
Table 8. Novo Nordisk Long Acting Insulins Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Novo Nordisk Recent Developments and Future Plans
Table 10. Sanofi Company Information, Head Office, and Major Competitors
Table 11. Sanofi Major Business
Table 12. Sanofi Long Acting Insulins Product and Solutions
Table 13. Sanofi Long Acting Insulins Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Sanofi Recent Developments and Future Plans
Table 15. Wockhardt UK Company Information, Head Office, and Major Competitors
Table 16. Wockhardt UK Major Business
Table 17. Wockhardt UK Long Acting Insulins Product and Solutions
Table 18. Wockhardt UK Long Acting Insulins Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Wockhardt UK Recent Developments and Future Plans
Table 20. Global Long Acting Insulins Revenue (USD Million) by Players (2019-2024)
Table 21. Global Long Acting Insulins Revenue Share by Players (2019-2024)
Table 22. Breakdown of Long Acting Insulins by Company Type (Tier 1, Tier 2, and Tier 3)
Table 23. Market Position of Players in Long Acting Insulins, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 24. Head Office of Key Long Acting Insulins Players
Table 25. Long Acting Insulins Market: Company Product Type Footprint
Table 26. Long Acting Insulins Market: Company Product Application Footprint
Table 27. Long Acting Insulins New Market Entrants and Barriers to Market Entry
Table 28. Long Acting Insulins Mergers, Acquisition, Agreements, and Collaborations
Table 29. Global Long Acting Insulins Consumption Value (USD Million) by Type (2019-2024)
Table 30. Global Long Acting Insulins Consumption Value Share by Type (2019-2024)
Table 31. Global Long Acting Insulins Consumption Value Forecast by Type (2025-2030)
Table 32. Global Long Acting Insulins Consumption Value by Application (2019-2024)
Table 33. Global Long Acting Insulins Consumption Value Forecast by Application (2025-2030)
Table 34. North America Long Acting Insulins Consumption Value by Type (2019-2024) & (USD Million)
Table 35. North America Long Acting Insulins Consumption Value by Type (2025-2030) & (USD Million)
Table 36. North America Long Acting Insulins Consumption Value by Application (2019-2024) & (USD Million)
Table 37. North America Long Acting Insulins Consumption Value by Application (2025-2030) & (USD Million)
Table 38. North America Long Acting Insulins Consumption Value by Country (2019-2024) & (USD Million)
Table 39. North America Long Acting Insulins Consumption Value by Country (2025-2030) & (USD Million)
Table 40. Europe Long Acting Insulins Consumption Value by Type (2019-2024) & (USD Million)
Table 41. Europe Long Acting Insulins Consumption Value by Type (2025-2030) & (USD Million)
Table 42. Europe Long Acting Insulins Consumption Value by Application (2019-2024) & (USD Million)
Table 43. Europe Long Acting Insulins Consumption Value by Application (2025-2030) & (USD Million)
Table 44. Europe Long Acting Insulins Consumption Value by Country (2019-2024) & (USD Million)
Table 45. Europe Long Acting Insulins Consumption Value by Country (2025-2030) & (USD Million)
Table 46. Asia-Pacific Long Acting Insulins Consumption Value by Type (2019-2024) & (USD Million)
Table 47. Asia-Pacific Long Acting Insulins Consumption Value by Type (2025-2030) & (USD Million)
Table 48. Asia-Pacific Long Acting Insulins Consumption Value by Application (2019-2024) & (USD Million)
Table 49. Asia-Pacific Long Acting Insulins Consumption Value by Application (2025-2030) & (USD Million)
Table 50. Asia-Pacific Long Acting Insulins Consumption Value by Region (2019-2024) & (USD Million)
Table 51. Asia-Pacific Long Acting Insulins Consumption Value by Region (2025-2030) & (USD Million)
Table 52. South America Long Acting Insulins Consumption Value by Type (2019-2024) & (USD Million)
Table 53. South America Long Acting Insulins Consumption Value by Type (2025-2030) & (USD Million)
Table 54. South America Long Acting Insulins Consumption Value by Application (2019-2024) & (USD Million)
Table 55. South America Long Acting Insulins Consumption Value by Application (2025-2030) & (USD Million)
Table 56. South America Long Acting Insulins Consumption Value by Country (2019-2024) & (USD Million)
Table 57. South America Long Acting Insulins Consumption Value by Country (2025-2030) & (USD Million)
Table 58. Middle East & Africa Long Acting Insulins Consumption Value by Type (2019-2024) & (USD Million)
Table 59. Middle East & Africa Long Acting Insulins Consumption Value by Type (2025-2030) & (USD Million)
Table 60. Middle East & Africa Long Acting Insulins Consumption Value by Application (2019-2024) & (USD Million)
Table 61. Middle East & Africa Long Acting Insulins Consumption Value by Application (2025-2030) & (USD Million)
Table 62. Middle East & Africa Long Acting Insulins Consumption Value by Country (2019-2024) & (USD Million)
Table 63. Middle East & Africa Long Acting Insulins Consumption Value by Country (2025-2030) & (USD Million)
Table 64. Long Acting Insulins Raw Material
Table 65. Key Suppliers of Long Acting Insulins Raw Materials
Table 1. Global Long Acting Insulins Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Long Acting Insulins Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Long Acting Insulins Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Long Acting Insulins Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Novo Nordisk Company Information, Head Office, and Major Competitors
Table 6. Novo Nordisk Major Business
Table 7. Novo Nordisk Long Acting Insulins Product and Solutions
Table 8. Novo Nordisk Long Acting Insulins Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Novo Nordisk Recent Developments and Future Plans
Table 10. Sanofi Company Information, Head Office, and Major Competitors
Table 11. Sanofi Major Business
Table 12. Sanofi Long Acting Insulins Product and Solutions
Table 13. Sanofi Long Acting Insulins Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Sanofi Recent Developments and Future Plans
Table 15. Wockhardt UK Company Information, Head Office, and Major Competitors
Table 16. Wockhardt UK Major Business
Table 17. Wockhardt UK Long Acting Insulins Product and Solutions
Table 18. Wockhardt UK Long Acting Insulins Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Wockhardt UK Recent Developments and Future Plans
Table 20. Global Long Acting Insulins Revenue (USD Million) by Players (2019-2024)
Table 21. Global Long Acting Insulins Revenue Share by Players (2019-2024)
Table 22. Breakdown of Long Acting Insulins by Company Type (Tier 1, Tier 2, and Tier 3)
Table 23. Market Position of Players in Long Acting Insulins, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 24. Head Office of Key Long Acting Insulins Players
Table 25. Long Acting Insulins Market: Company Product Type Footprint
Table 26. Long Acting Insulins Market: Company Product Application Footprint
Table 27. Long Acting Insulins New Market Entrants and Barriers to Market Entry
Table 28. Long Acting Insulins Mergers, Acquisition, Agreements, and Collaborations
Table 29. Global Long Acting Insulins Consumption Value (USD Million) by Type (2019-2024)
Table 30. Global Long Acting Insulins Consumption Value Share by Type (2019-2024)
Table 31. Global Long Acting Insulins Consumption Value Forecast by Type (2025-2030)
Table 32. Global Long Acting Insulins Consumption Value by Application (2019-2024)
Table 33. Global Long Acting Insulins Consumption Value Forecast by Application (2025-2030)
Table 34. North America Long Acting Insulins Consumption Value by Type (2019-2024) & (USD Million)
Table 35. North America Long Acting Insulins Consumption Value by Type (2025-2030) & (USD Million)
Table 36. North America Long Acting Insulins Consumption Value by Application (2019-2024) & (USD Million)
Table 37. North America Long Acting Insulins Consumption Value by Application (2025-2030) & (USD Million)
Table 38. North America Long Acting Insulins Consumption Value by Country (2019-2024) & (USD Million)
Table 39. North America Long Acting Insulins Consumption Value by Country (2025-2030) & (USD Million)
Table 40. Europe Long Acting Insulins Consumption Value by Type (2019-2024) & (USD Million)
Table 41. Europe Long Acting Insulins Consumption Value by Type (2025-2030) & (USD Million)
Table 42. Europe Long Acting Insulins Consumption Value by Application (2019-2024) & (USD Million)
Table 43. Europe Long Acting Insulins Consumption Value by Application (2025-2030) & (USD Million)
Table 44. Europe Long Acting Insulins Consumption Value by Country (2019-2024) & (USD Million)
Table 45. Europe Long Acting Insulins Consumption Value by Country (2025-2030) & (USD Million)
Table 46. Asia-Pacific Long Acting Insulins Consumption Value by Type (2019-2024) & (USD Million)
Table 47. Asia-Pacific Long Acting Insulins Consumption Value by Type (2025-2030) & (USD Million)
Table 48. Asia-Pacific Long Acting Insulins Consumption Value by Application (2019-2024) & (USD Million)
Table 49. Asia-Pacific Long Acting Insulins Consumption Value by Application (2025-2030) & (USD Million)
Table 50. Asia-Pacific Long Acting Insulins Consumption Value by Region (2019-2024) & (USD Million)
Table 51. Asia-Pacific Long Acting Insulins Consumption Value by Region (2025-2030) & (USD Million)
Table 52. South America Long Acting Insulins Consumption Value by Type (2019-2024) & (USD Million)
Table 53. South America Long Acting Insulins Consumption Value by Type (2025-2030) & (USD Million)
Table 54. South America Long Acting Insulins Consumption Value by Application (2019-2024) & (USD Million)
Table 55. South America Long Acting Insulins Consumption Value by Application (2025-2030) & (USD Million)
Table 56. South America Long Acting Insulins Consumption Value by Country (2019-2024) & (USD Million)
Table 57. South America Long Acting Insulins Consumption Value by Country (2025-2030) & (USD Million)
Table 58. Middle East & Africa Long Acting Insulins Consumption Value by Type (2019-2024) & (USD Million)
Table 59. Middle East & Africa Long Acting Insulins Consumption Value by Type (2025-2030) & (USD Million)
Table 60. Middle East & Africa Long Acting Insulins Consumption Value by Application (2019-2024) & (USD Million)
Table 61. Middle East & Africa Long Acting Insulins Consumption Value by Application (2025-2030) & (USD Million)
Table 62. Middle East & Africa Long Acting Insulins Consumption Value by Country (2019-2024) & (USD Million)
Table 63. Middle East & Africa Long Acting Insulins Consumption Value by Country (2025-2030) & (USD Million)
Table 64. Long Acting Insulins Raw Material
Table 65. Key Suppliers of Long Acting Insulins Raw Materials
LIST OF FIGURES
Figure 1. Long Acting Insulins Picture
Figure 2. Global Long Acting Insulins Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Long Acting Insulins Consumption Value Market Share by Type in 2023
Figure 4. Insulin Glargine
Figure 5. Insulin Determir
Figure 6. Insulin Degludec
Figure 7. Long Acting Animal Insulin
Figure 8. Global Long Acting Insulins Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 9. Long Acting Insulins Consumption Value Market Share by Application in 2023
Figure 10. Home Use Picture
Figure 11. Medical Institutions Picture
Figure 12. Others Picture
Figure 13. Global Long Acting Insulins Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Long Acting Insulins Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Market Long Acting Insulins Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 16. Global Long Acting Insulins Consumption Value Market Share by Region (2019-2030)
Figure 17. Global Long Acting Insulins Consumption Value Market Share by Region in 2023
Figure 18. North America Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 20. Asia-Pacific Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 21. South America Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 22. Middle East and Africa Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 23. Global Long Acting Insulins Revenue Share by Players in 2023
Figure 24. Long Acting Insulins Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 25. Global Top 3 Players Long Acting Insulins Market Share in 2023
Figure 26. Global Top 6 Players Long Acting Insulins Market Share in 2023
Figure 27. Global Long Acting Insulins Consumption Value Share by Type (2019-2024)
Figure 28. Global Long Acting Insulins Market Share Forecast by Type (2025-2030)
Figure 29. Global Long Acting Insulins Consumption Value Share by Application (2019-2024)
Figure 30. Global Long Acting Insulins Market Share Forecast by Application (2025-2030)
Figure 31. North America Long Acting Insulins Consumption Value Market Share by Type (2019-2030)
Figure 32. North America Long Acting Insulins Consumption Value Market Share by Application (2019-2030)
Figure 33. North America Long Acting Insulins Consumption Value Market Share by Country (2019-2030)
Figure 34. United States Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe Long Acting Insulins Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe Long Acting Insulins Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe Long Acting Insulins Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 41. France Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific Long Acting Insulins Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific Long Acting Insulins Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific Long Acting Insulins Consumption Value Market Share by Region (2019-2030)
Figure 48. China Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 51. India Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 54. South America Long Acting Insulins Consumption Value Market Share by Type (2019-2030)
Figure 55. South America Long Acting Insulins Consumption Value Market Share by Application (2019-2030)
Figure 56. South America Long Acting Insulins Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East and Africa Long Acting Insulins Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East and Africa Long Acting Insulins Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East and Africa Long Acting Insulins Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 65. Long Acting Insulins Market Drivers
Figure 66. Long Acting Insulins Market Restraints
Figure 67. Long Acting Insulins Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Long Acting Insulins in 2023
Figure 70. Manufacturing Process Analysis of Long Acting Insulins
Figure 71. Long Acting Insulins Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Figure 1. Long Acting Insulins Picture
Figure 2. Global Long Acting Insulins Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Long Acting Insulins Consumption Value Market Share by Type in 2023
Figure 4. Insulin Glargine
Figure 5. Insulin Determir
Figure 6. Insulin Degludec
Figure 7. Long Acting Animal Insulin
Figure 8. Global Long Acting Insulins Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 9. Long Acting Insulins Consumption Value Market Share by Application in 2023
Figure 10. Home Use Picture
Figure 11. Medical Institutions Picture
Figure 12. Others Picture
Figure 13. Global Long Acting Insulins Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Long Acting Insulins Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Market Long Acting Insulins Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 16. Global Long Acting Insulins Consumption Value Market Share by Region (2019-2030)
Figure 17. Global Long Acting Insulins Consumption Value Market Share by Region in 2023
Figure 18. North America Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 20. Asia-Pacific Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 21. South America Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 22. Middle East and Africa Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 23. Global Long Acting Insulins Revenue Share by Players in 2023
Figure 24. Long Acting Insulins Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 25. Global Top 3 Players Long Acting Insulins Market Share in 2023
Figure 26. Global Top 6 Players Long Acting Insulins Market Share in 2023
Figure 27. Global Long Acting Insulins Consumption Value Share by Type (2019-2024)
Figure 28. Global Long Acting Insulins Market Share Forecast by Type (2025-2030)
Figure 29. Global Long Acting Insulins Consumption Value Share by Application (2019-2024)
Figure 30. Global Long Acting Insulins Market Share Forecast by Application (2025-2030)
Figure 31. North America Long Acting Insulins Consumption Value Market Share by Type (2019-2030)
Figure 32. North America Long Acting Insulins Consumption Value Market Share by Application (2019-2030)
Figure 33. North America Long Acting Insulins Consumption Value Market Share by Country (2019-2030)
Figure 34. United States Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe Long Acting Insulins Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe Long Acting Insulins Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe Long Acting Insulins Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 41. France Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific Long Acting Insulins Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific Long Acting Insulins Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific Long Acting Insulins Consumption Value Market Share by Region (2019-2030)
Figure 48. China Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 51. India Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 54. South America Long Acting Insulins Consumption Value Market Share by Type (2019-2030)
Figure 55. South America Long Acting Insulins Consumption Value Market Share by Application (2019-2030)
Figure 56. South America Long Acting Insulins Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East and Africa Long Acting Insulins Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East and Africa Long Acting Insulins Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East and Africa Long Acting Insulins Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE Long Acting Insulins Consumption Value (2019-2030) & (USD Million)
Figure 65. Long Acting Insulins Market Drivers
Figure 66. Long Acting Insulins Market Restraints
Figure 67. Long Acting Insulins Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Long Acting Insulins in 2023
Figure 70. Manufacturing Process Analysis of Long Acting Insulins
Figure 71. Long Acting Insulins Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
